Unknown

Dataset Information

0

Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.


ABSTRACT:

Background

N-stage is related to distant metastasis in nasopharyngeal carcinoma (NPC) patients. The purpose of this study was to evaluate the efficacy and toxicity of different nedaplatin-based chemotherapy regimens in advanced N2-3 stage NPC patients treated with intensity modulated radiation therapy (IMRT).

Patients and methods

Between April 2005 and December 2009, a total of 128 patients with N2-3 advanced NPC were retrospectively analyzed. Patients were treated with IMRT concurrent with 2 cycles of chemotherapy consisting of either nedaplatin plus paclitaxel (NP group, n = 67) or nedaplatin plus fluorouracil and paclitaxel (NFP group, n = 61). Two to four cycles of adjuvant chemotherapy were then administered every 21 days following concurrent chemoradiotherapy.

Results

With a median follow-up of 60 months, the 5-year overall survival (OS), progression-free survival (PFS), local-regional recurrence-free survival (LRRFS), and distant metastasis-free survival (DMFS) for all patients were 81.4%, 71.5%, 87.8% and 82.0%, respectively. No significant difference in PFS (66.6% vs. 76.7%, P = 0.212) and LRRFS rates (89.0% vs. 86.3%, P = 0.664) was observed between the NP and NFP groups. The 5-year OS (75.4% vs. 88.5%, P = 0.046) and DMFS (75.1% vs. 89.0%, P = 0.042) rate were superior in the NFP group compared with the NP group. The NFP group had a higher incidence of grade 3-4 acute toxicities including bone marrow suppression (leukopenia: ?2 = 3.935, P = 0.047; anemia: ?2 = 9.760, P = 0.002; thrombocytopenia: ?2 = 8.821, P = 0.003), and both liver and renal dysfunction (?2 = 5.206, P = 0.023) compared with the NP group. Late toxicities were moderate and no difference was observed between the two groups.

Conclusion

IMRT concurrent with nedaplatin-based chemotherapy is an advocated regimen for patients with advanced N2-3 stage NPC. Patients with advanced N2-3 stage may be better candidates for the NFP regimen although this regimen was associated with a high acute toxicity rate.

SUBMITTER: Yin L 

PROVIDER: S-EPMC4569428 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Long-Term Results of Concurrent Chemoradiotherapy for Advanced N2-3 Stage Nasopharyngeal Carcinoma.

Yin Li L   Bian Xiu-Hua XH   Wang Xue X   Chen Meng M   Wu Jing J   Xu Jian-Hua JH   Qian Pu-Dong PD   Guo Wen-Jie WJ   Jiang Xue-Song XS   Zhu Huan-Feng HF   Gu Jia-Jia JJ   Wu Jian-Feng JF   Zhang Ye-wei YW   He Xia X  

PloS one 20150914 9


<h4>Background</h4>N-stage is related to distant metastasis in nasopharyngeal carcinoma (NPC) patients. The purpose of this study was to evaluate the efficacy and toxicity of different nedaplatin-based chemotherapy regimens in advanced N2-3 stage NPC patients treated with intensity modulated radiation therapy (IMRT).<h4>Patients and methods</h4>Between April 2005 and December 2009, a total of 128 patients with N2-3 advanced NPC were retrospectively analyzed. Patients were treated with IMRT concu  ...[more]

Similar Datasets

| S-EPMC7871351 | biostudies-literature
| S-EPMC6127191 | biostudies-other
| S-EPMC5694200 | biostudies-literature
| S-EPMC5870479 | biostudies-literature
| S-EPMC6491187 | biostudies-literature
| S-EPMC6692629 | biostudies-literature
| S-EPMC6431774 | biostudies-literature
| S-EPMC6876219 | biostudies-literature
| S-EPMC5029712 | biostudies-literature
| S-EPMC4829825 | biostudies-other